Astrana Health, Inc. (ASTH)
$
24.66
-0.28 (-1.14%)
Key metrics
Financial statements
Free cash flow per share
1.1385
Market cap
1.2 Billion
Price to sales ratio
0.5533
Debt to equity
0.8670
Current ratio
0.7915
Income quality
1.4016
Average inventory
0
ROE
0.0651
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Astrana Health, Inc., a physician-centric technology-driven healthcare management company, recorded an operating income of $89,350,000.00 reflecting its earnings from core operations. The gross profit ratio stands at 0.13 indicating the efficiency of the company's production and sales operations. Additionally, the company incurred an interest expense of $33,097,000.00 which denotes its obligations related to debt servicing. The diluted EPS is $0.89 accounting for potential share dilution, and the net income ratio is 0.02 illustrating the company's profitability margin. Operating through its Care Partners, Care Delivery, and Care Enablement segments, Astrana Health utilizes its proprietary population health management and healthcare delivery platform to facilitate an integrated, value-based healthcare model, empowering the diverse providers within its network. The firm extends care coordination services to patients, families, and various health entities including primary care physicians, specialists, and health plans, ensuring a cohesive approach to patient care. Primarily serving patients with private or public insurance such as Medicare, Medicaid, health maintenance organization plans, as well as non-insured individuals, Astrana Health plays a vital role in the healthcare landscape. Formerly known as Apollo Medical Holdings, Inc., the company adopted its current name in February 2024 and has been incorporated since 1985, with its headquarters located in Alhambra, California. The stock is affordable at $24.66 making it suitable for budget-conscious investors. Moreover, it exhibits a low average trading volume of 281,600.00 indicating lower market activity which may appeal to certain investment strategies. With a market capitalization of $1,231,246,674.00 the company is classified as a small-cap player, situating it in a unique position within its industry. It is regarded as a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. Furthermore, the company belongs to the Healthcare sector, driving innovation and growth, thus attracting attention from investors who are looking for opportunities in emerging and stable markets alike.
Is Astrana Health, Inc. (ASTH) a good investment?
Investing in Astrana Health, Inc. (ASTH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bullish outlook. Always conduct your own research before investing.
What is Astrana Health, Inc. (ASTH)'s stock forecast?
Analysts predict Astrana Health, Inc. stock to fluctuate between $23.12 (low) and $63.20 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Astrana Health, Inc.'s market capitalization?
As of 2025-06-17, Astrana Health, Inc.'s market cap is $1,231,246,674, based on 49,928,900 outstanding shares.
How does Astrana Health, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Astrana Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Astrana Health, Inc. (ASTH) stock?
To buy Astrana Health, Inc. (ASTH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ASTH. Place an order (Market, Limit, etc.).
What is the best time to invest in Astrana Health, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Astrana Health, Inc. stock ever split?
Astrana Health, Inc.'s last stock split was 1:10 on 2015-04-27.
How did Astrana Health, Inc. perform in the last earnings report?
Revenue: $2,034,540,000 | EPS: $0.90 | Growth: -30.77%.
Where can I find Astrana Health, Inc.'s investor relations reports?
Visit https://www.astranahealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Astrana Health, Inc.?
You can explore historical data from here
What is the all-time high and low for Astrana Health, Inc. stock?
All-time high: $63.20 (2024-10-16) | All-time low: $23.12 (2025-02-28).
What are the key trends affecting Astrana Health, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
ALHAMBRA, Calif. , June 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO is participating in the William Blair 2025 Growth Stock Conference, being held in Chicago, from Tuesday, June 3, 2025 to Thursday June 5, 2025 including a presentation at 10:40 am CT on Wednesday, June 4.
seekingalpha.com
Astrana Health, Inc. (NASDAQ:ASTH ) Q1 2025 Earnings Conference Call May 8, 2025 5:30 PM ET Company Participants Brandon Sim - President & Chief Executive Officer Chan Basho - Chief Operating & Financial Officer. Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jack Slevin - Jefferies Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Brooks O'Neil - Lake Street Capital Markets David Larsen - BTIG Gene Mannheimer - Freedom Capital Markets Thomas Walsh - Barclays Operator Good day, everyone, and welcome to today's Astrana's Health First Quarter 2025 Earnings Call.
seekingalpha.com
Astrana Health, Inc. (NASDAQ:ASTH ) Q4 2024 Earnings Conference Call February 27, 2025 5:30 PM ET Company Participants Brandon Sim - President & CEO Chan Basho - Chief Operating & Financial Officer Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Adam Ron - Bank of America Craig Jones – Stifel Brooks O'Neil - Lake Street Capital David Larsen - BTIG Matt Gilmore - KeyBanc Capital Gene Mannheimer - Freedom Capital Markets Operator Good day, everyone, and welcome to today's Astrana Health Fourth Quarter and Full Year 2024 Earnings Call. [Operator Instructions] Later, you will have the opportunity to ask questions during the question-and-answer session.
zacks.com
Astrana Health, Inc. (ASTH) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.26 per share a year ago.
prnewswire.com
Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m.
prnewswire.com
ALHAMBRA, Calif. , Feb. 17, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024, after the close of the stock market on Thursday, February 27, 2025.
See all news
